Literature DB >> 31319302

Acute and chronic effects of perfluoroalkyl substance mixtures on larval American bullfrogs (Rana catesbeiana).

R Wesley Flynn1, Michael F Chislock2, Megan E Gannon3, Stephanie J Bauer3, Brian J Tornabene4, Jason T Hoverman3, Maria S Sepúlveda3.   

Abstract

Discovery of elevated concentrations of perfluoroalkyl substances (PFAS) in ground and surface waters globally has heightened concern over their potential adverse health effects. The effects of PFAS are known largely from acute toxicity studies of single PFAS compounds in model organisms, while little is understood concerning effects of mixtures on wildlife. To address this gap, we examined the acute and chronic effects of two of the most common PFAS (perfluorooctanesulfonic acid [PFOS] and perfluorooctanoic acid [PFOA]) and their mixtures on survival, growth, and development of American bullfrog (Rana catesbeiana) tadpoles. In 96 h acute toxicity tests, PFOS was 10X more toxic than PFOA and effects of the two chemicals in combination appeared additive. The effects of PFOS, PFOA, and their interaction varied by the sublethal endpoint under consideration in a 72 d exposure. Effects of PFAS on tadpole mass and developmental stage were largely driven by PFOS and there was no evidence of interactions suggesting deviations from additivity. However, for snout-vent length, reductions in length in mixture treatments were greater than expected based on the effects of the two chemicals independently (i.e. non-additivity). Further, effects on snout-vent length in single chemical exposures were only observed with PFOA. Our results highlight the importance of assessing combined effects of PFAS co-occurring in the environment and suggest caution in extrapolating the effects of acute toxicity studies to more environmentally relevant exposures. Future studies examining effects of environmentally relevant mixtures on wildlife will be essential for effective environmental risk assessment and management.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 31319302     DOI: 10.1016/j.chemosphere.2019.124350

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  6 in total

1.  Predicting the effects of per- and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro.

Authors:  Greylin Nielsen; Wendy J Heiger-Bernays; Jennifer J Schlezinger; Thomas F Webster
Journal:  Toxicology       Date:  2021-11-04       Impact factor: 4.221

2.  Per- and polyfluoroalkyl substances exposure and bone mineral density in the U.S. population from NHANES 2005-2014.

Authors:  Meng-Ling Tang; Shi-Gui Yan; Xiang Zhao; Ji-Yan Lin; Wen-Wei Dong
Journal:  J Expo Sci Environ Epidemiol       Date:  2022-06-24       Impact factor: 5.563

Review 3.  Translocation, bioaccumulation, and distribution of perfluoroalkyl and polyfluoroalkyl substances (PFASs) in plants.

Authors:  Bentuo Xu; Wenhui Qiu; Juan Du; Zhenning Wan; John L Zhou; Honghong Chen; Renlan Liu; Jason T Magnuson; Chunmiao Zheng
Journal:  iScience       Date:  2022-03-11

4.  Toxicokinetic Modeling of Per- and Polyfluoroalkyl Substance Concentrations within Developing Zebrafish (Danio rerio) Populations.

Authors:  Ross M Warner; Lisa M Sweeney; Brett A Hayhurst; Michael L Mayo
Journal:  Environ Sci Technol       Date:  2022-09-02       Impact factor: 11.357

5.  Comparative Toxicity of Aquatic Per- and Polyfluoroalkyl Substance Exposure in Three Species of Amphibians.

Authors:  R Wesley Flynn; Gary Hoover; Michael Iacchetta; Samuel Guffey; Chloe de Perre; Belinda Huerta; Weiming Li; Jason T Hoverman; Linda Lee; Maria S Sepúlveda
Journal:  Environ Toxicol Chem       Date:  2022-03-31       Impact factor: 4.218

Review 6.  Per- and Polyfluoroalkyl Substances (PFAS) Neurotoxicity in Sentinel and Non-Traditional Laboratory Model Systems: Potential Utility in Predicting Adverse Outcomes in Human Health.

Authors:  Rachel Foguth; Maria S Sepúlveda; Jason Cannon
Journal:  Toxics       Date:  2020-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.